AbbVie, a research-based global biopharmaceutical company, announced that it has completed its acquisition of Allergan plc following receipt of regulatory approval from all government authorities required by the transaction agreement

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In